Prof. Rami Kantor is an internal medicine and infectious diseases physician-scientist and a professor of medicine in the Division of Infectious Diseases. He was recruited to Brown University in 2005, after conducting post-doctoral HIV research fellowship at Stanford University. He completed his medical studies and internal medicine residency in Israel and his clinical infectious diseases training at Brown University/Lifespan. He directs the Drug Resistance Laboratory at the Providence-Boston Center for AIDS Research (CFAR) and co-directs the CFAR Basic Science Core. He is a past chair of the HIV Comorbidities and Clinical Studies (HCCS) NIH study section, a member of the Department of Health and Human Services (DHHS) Guidelines Panel for HIV Treatment in Adults and Adolescents, and deputy editor and editorial board member of the Journal of the International AIDS Society. His multidisciplinary clinical and basic science research includes the evolution of antiretroviral resistance, treatment monitoring, and transmission in people living with HIV. He is involved in national and international collaborations, with a focus on HIV/AIDS locally and in resource-limited settings, where diverse HIV variants predominate. He has been part of networks such as the HIV Non-Subtype B Workgroup, the World Health Organization HIV Drug Resistance Network, the AIDS Clinical Trials Group (ACTG), TREAT Asia, and the International Epidemiologic Databases to Evaluate AIDS (IeDEA).
Prof. Rami Kantor is an internal medicine and infectious diseases physician-scientist and a professor of medicine in the Division of Infectious Diseases. He was recruited to Brown University in 2005, after conducting post-doctoral HIV research fellowship at Stanford University. He completed his medical studies and internal medicine residency in Israel and his clinical infectious diseases training at Brown University/Lifespan. He directs the Drug Resistance Laboratory at the Providence-Boston Center for AIDS Research (CFAR) and co-directs the CFAR Basic Science Core. He is a past chair of the HIV Comorbidities and Clinical Studies (HCCS) NIH study section, a member of the Department of Health and Human Services (DHHS) Guidelines Panel for HIV Treatment in Adults and Adolescents, and deputy editor and editorial board member of the Journal of the International AIDS Society. His multidisciplinary clinical and basic science research includes the evolution of antiretroviral resistance, treatment monitoring, and transmission in people living with HIV. He is involved in national and international collaborations, with a focus on HIV/AIDS locally and in resource-limited settings, where diverse HIV variants predominate. He has been part of networks such as the HIV Non-Subtype B Workgroup, the World Health Organization HIV Drug Resistance Network, the AIDS Clinical Trials Group (ACTG), TREAT Asia, and the International Epidemiologic Databases to Evaluate AIDS (IeDEA).